...
首页> 外文期刊>Molecular cancer research: MCR >Molecular Portrait of Hypoxia in Breast Cancer: A Prognostic Signature and Novel HIF-Regulated Genes
【24h】

Molecular Portrait of Hypoxia in Breast Cancer: A Prognostic Signature and Novel HIF-Regulated Genes

机译:缺氧在乳腺癌中的分子画象:预后签名和新的HIF调节基因

获取原文
获取原文并翻译 | 示例

摘要

Intratumoral hypoxia has been associated with invasion, metastasis, and treatment failure, prompting the need for a global characterization of the response to hypoxic conditions. The current study presents the results of a large-scale RNA sequencing (RNA-seq) effort, analyzing 31 breast cancer cell lines representative of breast cancer subtypes or normal mammary epithelial (NME) cells exposed to control tissue culture conditions (20% O-2) or hypoxic conditions (1% O-2). The results demonstrate that NME have a stronger response to hypoxia both in terms of number of genes induced by hypoxia as well as level of expression. A conserved 42-gene hypoxia signature shared across PAM50 subtypes and genes that are exclusively upregulated in Luminal A, Luminal B, and normal-like mammary epithelial cells is identified. The 42-gene expression signature is enriched in a subset of basal-like cell lines and tumors and differentiates survival among patients with basal-like tumors. Mechanistically, the hypoxia-inducible factors (HIF-1 and/or HIF-2) mediate the conserved hypoxic response. Also, four novel hypoxia-regulated and HIF-1-responsive genes were identified as part of the conserved signature. This dataset provides a novel resource to query transcriptional changes th at occur in response to hypoxia and serves as a starting point for a clinical assay to aid in stratifying patients that would benefit from hypoxia-targeted therapies, some of which are currently in clinical trials.
机译:肿瘤缺氧已经与侵袭,转移和治疗失败有关,促使需要全球对缺氧条件的反应的表征。目前的研究表明了大规模的RNA测序(RNA-SEQ)努力的结果,分析了31种乳腺癌亚型或正常乳腺上皮(NME)细胞的乳腺癌细胞系暴露于控制组织培养条件(20% - 2)或缺氧条件(1%O-2)。结果表明,NME在缺氧诱导的基因以及表达水平方面对缺氧的反应较强。鉴定了横跨PAM50亚型的保守的42-基因缺氧签名和在腔A,腔B和正常样的乳腺上皮细胞中公共上调的基因。 42-基因表达签名富集在基类细胞系和肿瘤的子集中,并在基础肿瘤患者中区分存活率。机械地,缺氧诱导因子(HIF-1和/或HIF-2)介导保守的缺氧反应。此外,将四种新的缺氧和HIF-1响应基因鉴定为保守签名的一部分。该数据集提供了一种新的资源来查询因缺氧而发生的转录变化,并用作临床试验的起点,以帮助从缺氧靶向治疗中受益的分层患者,其中一些目前正在临床试验中。

著录项

  • 来源
    《Molecular cancer research: MCR 》 |2018年第12期| 共13页
  • 作者单位

    Johns Hopkins Univ Sch Med Sidney Kimmel Comprehens Canc Ctr Dept Oncol Baltimore MD USA;

    Johns Hopkins Univ Sch Med Sidney Kimmel Comprehens Canc Ctr Dept Oncol Baltimore MD USA;

    Johns Hopkins Univ Sch Med Sidney Kimmel Comprehens Canc Ctr Dept Oncol Baltimore MD USA;

    Johns Hopkins Univ Sch Med Sidney Kimmel Comprehens Canc Ctr Dept Oncol Baltimore MD USA;

    Johns Hopkins Univ Sch Med Sidney Kimmel Comprehens Canc Ctr Dept Oncol Baltimore MD USA;

    Johns Hopkins Univ Sch Med Sidney Kimmel Comprehens Canc Ctr Dept Oncol Baltimore MD USA;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 肿瘤学 ;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号